Original Research
Accepted on 02 Sep 2024
Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 02 Sep 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 02 Sep 2024
in Gynecological Oncology
Editorial
Accepted on 02 Sep 2024
in Children and Health
Mini Review
Accepted on 02 Sep 2024
in Red Blood Cell Physiology
Review
Accepted on 02 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Editorial
Accepted on 02 Sep 2024
in Clinical Diabetes
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Original Research
Accepted on 02 Sep 2024
in Gynecological Oncology
Original Research
Accepted on 02 Sep 2024
in Head and Neck Cancer
Original Research
Accepted on 02 Sep 2024
in Nutritional Epidemiology
Review
Accepted on 02 Sep 2024
in Gastrointestinal Sciences
Original Research
Accepted on 02 Sep 2024
in Animal Nutrition and Metabolism
Mini Review
Accepted on 02 Sep 2024
in Chemical Biology
Hypothesis and Theory
Accepted on 02 Sep 2024
in Work, Employment and Organizations
Original Research
Accepted on 02 Sep 2024
in Neuro-Oncology and Neurosurgical Oncology